Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148523 · ClinicalTrials.gov registry record · NA
Social Forces to Improve Statin Adherence (Study B)
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
NCT02148523: Completed NA study, sponsored by University of Pennsylvania.
NCT02148523 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02148523, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
Study Summary
To assess the effectiveness of social comparison in improving the outcome of statin adherence versus usual care as measured by an electronic pill bottle. Subjects receiving weekly reports with their adherence and information about their place in the distribution of their peers will have the highest statin adherence of any arm, as measured by electronic pill bottle.
Primary Outcome
The primary outcome will be the percent of statin doses taken during the study as measured by the GlowCaps.
Interventions
- DEVICE Electronic pill bottle
- BEHAVIORAL Comparison to peers
- BEHAVIORAL Adherence feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT02148523 record still lists
NCT02148523 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which Electronic pill bottle is the first listed.
NCT02148523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02148523 about?
NCT02148523 is a clinical study titled "Social Forces to Improve Statin Adherence (Study B)". To assess the effectiveness of social comparison in improving the outcome of statin adherence versus usual care as measured by an electronic pill bottle. Subjects receiving weekly reports with their adherence and information about their place in the distribution of their peers will have the highest...
What is the current status of trial NCT02148523?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2014-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02148523?
The interventions under investigation include: Electronic pill bottle (DEVICE), Comparison to peers (BEHAVIORAL), Adherence feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02148523?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02148523's enrollment target sits among peer trials
201 506th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia